Vanguard Group’s Eledon Pharmaceuticals ELDN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.99M | Buy |
3,318,383
+365,256
| +12% | +$990K | ﹤0.01% | 2959 |
|
|
2025
Q1 | $10M | Buy |
2,953,127
+58,488
| +2% | +$198K | ﹤0.01% | 2846 |
|
|
2024
Q4 | $11.9M | Buy |
2,894,639
+1,329,152
| +85% | +$5.48M | ﹤0.01% | 2859 |
|
|
2024
Q3 | $3.9M | Buy |
1,565,487
+461,092
| +42% | +$1.15M | ﹤0.01% | 3363 |
|
|
2024
Q2 | $2.92M | Buy |
1,104,395
+135,274
| +14% | +$357K | ﹤0.01% | 3450 |
|
|
2024
Q1 | $2M | Buy |
969,121
+273,703
| +39% | +$564K | ﹤0.01% | 3594 |
|
|
2023
Q4 | $1.25M | Buy |
695,418
+20,898
| +3% | +$37.6K | ﹤0.01% | 3750 |
|
|
2023
Q3 | $924K | Sell |
674,520
-5,037
| -0.7% | -$6.9K | ﹤0.01% | 3864 |
|
|
2023
Q2 | $931K | Hold |
679,557
| – | – | ﹤0.01% | 3925 |
|
|
2023
Q1 | $1.6M | Hold |
679,557
| – | – | ﹤0.01% | 3753 |
|
|
2022
Q4 | $1.55M | Buy |
679,557
+314
| +0% | +$716 | ﹤0.01% | 3761 |
|
|
2022
Q3 | $1.88M | Hold |
679,243
| – | – | ﹤0.01% | 3770 |
|
|
2022
Q2 | $1.66M | Hold |
679,243
| – | – | ﹤0.01% | 3885 |
|
|
2022
Q1 | $2.68M | Buy |
679,243
+9,543
| +1% | +$37.6K | ﹤0.01% | 3833 |
|
|
2021
Q4 | $2.95M | Sell |
669,700
-813
| -0.1% | -$3.59K | ﹤0.01% | 3876 |
|
|
2021
Q3 | $4.14M | Buy |
670,513
+460,763
| +220% | +$2.85M | ﹤0.01% | 3775 |
|
|
2021
Q2 | $1.66M | Sell |
209,750
-20,294
| -9% | -$161K | ﹤0.01% | 4019 |
|
|
2021
Q1 | $2.46M | Buy |
230,044
+226,001
| +5,590% | +$2.42M | ﹤0.01% | 3818 |
|
|
2020
Q4 | $62K | Sell |
4,043
-50,747
| -93% | -$778K | ﹤0.01% | 4171 |
|
|
2020
Q3 | $52K | Hold |
54,790
| – | – | ﹤0.01% | 4064 |
|
|
2020
Q2 | $25K | Buy |
54,790
+17,100
| +45% | +$7.8K | ﹤0.01% | 4055 |
|
|
2020
Q1 | $15K | Hold |
37,690
| – | – | ﹤0.01% | 4057 |
|
|
2019
Q4 | $22K | Sell |
37,690
-25,071
| -40% | -$14.6K | ﹤0.01% | 4084 |
|
|
2019
Q3 | $39K | Sell |
62,761
-207,399
| -77% | -$129K | ﹤0.01% | 4097 |
|
|
2019
Q2 | $273K | Buy |
270,160
+227,157
| +528% | +$230K | ﹤0.01% | 3924 |
|
|
2019
Q1 | $173K | Buy |
43,003
+600
| +1% | +$2.41K | ﹤0.01% | 3949 |
|
|
2018
Q4 | $68K | Sell |
42,403
-93,196
| -69% | -$149K | ﹤0.01% | 4045 |
|
|
2018
Q3 | $633K | Buy |
135,599
+57,450
| +74% | +$268K | ﹤0.01% | 3810 |
|
|
2018
Q2 | $547K | Buy |
78,149
+34,238
| +78% | +$240K | ﹤0.01% | 3809 |
|
|
2018
Q1 | $212K | Buy |
43,911
+425
| +1% | +$2.05K | ﹤0.01% | 3944 |
|
|
2017
Q4 | $168K | Sell |
43,486
-1,582
| -4% | -$6.11K | ﹤0.01% | 3953 |
|
|
2017
Q3 | $235K | Buy |
45,068
+2,265
| +5% | +$11.8K | ﹤0.01% | 3884 |
|
|
2017
Q2 | $251K | Sell |
42,803
-367,010
| -90% | -$2.15M | ﹤0.01% | 3860 |
|
|
2017
Q1 | $343K | Buy |
409,813
+75,450
| +23% | +$63.1K | ﹤0.01% | 3813 |
|
|
2016
Q4 | $327K | Buy |
334,363
+222,909
| +200% | +$218K | ﹤0.01% | 3811 |
|
|
2016
Q3 | $171K | Sell |
111,454
-145,128
| -57% | -$223K | ﹤0.01% | 3924 |
|
|
2016
Q2 | $1.41M | Buy |
256,582
+7,097
| +3% | +$39.1K | ﹤0.01% | 3499 |
|
|
2016
Q1 | $1.4M | Buy |
249,485
+9,019
| +4% | +$50.6K | ﹤0.01% | 3493 |
|
|
2015
Q4 | $2.1M | Buy |
240,466
+10,510
| +5% | +$91.7K | ﹤0.01% | 3379 |
|
|
2015
Q3 | $2.38M | Buy |
229,956
+28,244
| +14% | +$292K | ﹤0.01% | 3294 |
|
|
2015
Q2 | $2.68M | Buy |
201,712
+10,039
| +5% | +$134K | ﹤0.01% | 3297 |
|
|
2015
Q1 | $2.17M | Buy |
191,673
+33,317
| +21% | +$376K | ﹤0.01% | 3374 |
|
|
2014
Q4 | $2.33M | Buy |
+158,356
| New | +$2.33M | ﹤0.01% | 3229 |
|